OncoMed Pharmaceuticals
Redwood City
About OncoMed Pharmaceuticals
OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as “cancer stem cells“. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $210.1M
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2013)
- Ticker: nasdaq:OMED
- Website: oncomed.com
- Phone: 650-995-8200
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/oncomed-pharmaceuticals-3728144 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.